Chiaki Inagaki, Ryo Matoba, Eisuke Inoue, Daisuke Kotani, Tadamichi Denda, Tomomi Kashiwada, Yoshiaki Mihara, Akinori Sugaya, Yusuke Suwa, Takashi Ohta, Hidekazu Kuramochi, Kotoe Oshima, Chihiro Tanaka, Toshihiro Kudo, Satoshi Yuki, Manabu Shiozawa, Akihito Tsuji, Kei Muro, Wataru Ichikawa, Yu Sunakawa. "Overall survival benefit of doublet versus triplet BRAF inhibitor–based therapy: Insights from the BEETS study (JACCRO CC-18).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.3540